Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acinetobacter Baumannii-calcoaceticus Complex Infections”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07431307
What this trial is testing

Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Who this might be right for
Ventilator Associated Bacterial Pneumonia (VABP)Hospital Acquired Bacterial Pneumonia (HABP)Blood Stream Infection+2 more
BioVersys AG 120
Large-scale testing (Phase 3)Study completedNCT03894046
What this trial is testing

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

Who this might be right for
Acinetobacter Baumannii-calcoaceticus ComplexHospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia+2 more
Entasis Therapeutics 207
Early research (Phase 1)Study completedNCT04018950
What this trial is testing

Study to Determine the Excretion and Metabolism of 14C-ETX2514 Administered Intravenously in Healthy Male Subjects

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infections
Entasis Therapeutics 8
Early research (Phase 1)Looking for participantsNCT06801223
What this trial is testing

Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Innoviva Specialty Therapeutics 48
Not applicableActive Not RecruitingNCT07226557
What this trial is testing

Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation

Who this might be right for
Carbapenem Resistant Bacterial InfectionAcinetobacter Baumannii InfectionAntimicrobial Drug Resistance
National Institutes of Health Clinical Center (CC) 5,000
Early research (Phase 1)Study completedNCT03985410
What this trial is testing

Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infections
Entasis Therapeutics 32
Not applicableLooking for participantsNCT06746883
What this trial is testing

Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Innoviva Specialty Therapeutics 100